Home
About
Services
Partners
Client Portfolio
News
Contact
Truckmaker Volvo to take $778 million emissions hit
January 3, 2019
Southwest Airlines co-founder Herb Kelleher dies
January 3, 2019
0
Bristol-Myers to buy Celgene for $74 billion in largest biopharma deal
Published by
Muller&Green
at
January 3, 2019
Categories
RSS
Tags
Bristol-Myers Squibb Co said on Thursday it would buy Celgene Corp for about $74 billion, combining two of the world’s largest cancer drug businesses in the biggest pharmaceutical deal ever.
Powered by
WPeMatico
Muller&Green
Related posts
June 18, 2020
Chanel warns virus impact will linger on luxury sector
Read more
June 18, 2020
IMF says deeper-than-expected contraction in U.S. economy likely in second quarter
Read more
June 18, 2020
Prudential sells Jackson equity stake to Apollo-backed Athene for $500 million
Read more